ArticleUrology case reports2025
Solitary fibrous tumor of the prostate: Case report and literature review.
Article in Urology case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- [Solitary fibrous tumor of the prostate mimicking a tumor of the vesicoprostatic junction. Case report].Revista medica del Instituto Mexicano del Seguro Social · 2026Article
- Paratesticular Solitary Fibrous Tumor: A Case Report With Sonographic and Histopathologic Insights.Cureus · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Solitary fibrous tumor (SFT) of the prostate is a rare mesenchymal neoplasm with only a few cases reported. Its clinical presentation often mimics benign prostatic hyperplasia, and imaging findings are nonspecific. Diagnosis relies on histopathology and immunohistochemistry, particularly STAT6 nuclear expression. Most cases follow a benign course, but some may exhibit aggressive behavior. Complete surgical resection with clear margins is the treatment of choice, with no established role for adjuvant therapy. This report discusses a case of prostatic SFT, emphasizing its diagnostic challenges, imaging findings, and surgical management, contributing to the limited literature on this rare entity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.